Aimei Health Technology Files 8-K on Financial Obligations
Ticker: AFJKR · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1979005
Sentiment: neutral
Topics: financial-obligation, 8-k
TL;DR
Aimei Health Tech just filed an 8-K about a new financial obligation. Keep an eye on this.
AI Summary
Aimei Health Technology Co., Ltd. filed an 8-K on October 9, 2025, reporting on events that occurred on October 8, 2025. The filing indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. The company is incorporated in the Cayman Islands and its principal executive offices are located in New York.
Why It Matters
This 8-K filing signals a potential new financial commitment or liability for Aimei Health Technology, which could impact its financial health and future operations.
Risk Assessment
Risk Level: medium — The filing indicates a new financial obligation, which inherently carries some level of risk until more details are disclosed.
Key Players & Entities
- Aimei Health Technology Co., Ltd. (company) — Registrant
- October 8, 2025 (date) — Date of earliest event reported
- October 9, 2025 (date) — Filing date
- Cayman Islands (location) — Jurisdiction of incorporation
- New York (location) — Business address city
FAQ
What specific financial obligation is Aimei Health Technology Co., Ltd. reporting?
The filing states the creation of a 'Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement' but does not specify the exact nature or amount of the obligation in the provided text.
When did the event triggering this 8-K filing occur?
The earliest event reported occurred on October 8, 2025.
What is the filing date of this 8-K report?
The 8-K report was filed on October 9, 2025.
Where is Aimei Health Technology Co., Ltd. incorporated?
The company is incorporated in the Cayman Islands.
What is the primary business classification listed for Aimei Health Technology?
The Standard Industrial Classification (SIC) code listed is 6770, which corresponds to 'BLANK CHECKS'.
Filing Stats: 790 words · 3 min read · ~3 pages · Grade level 13.9 · Accepted 2025-10-08 21:20:17
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $150,000 — the Termination Date An aggregate of $150,000 (the " Extension Payment ") has been de
- $75,000 — ween the Payees, with each contributing $75,000, to fund the Extension Payment. The Pro
- $10.00 — ate units of the Company, at a price of $10.00 per unit, each consisting of one ordina
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 43KB
- 0001493152-25-017497.txt ( ) — 315KB
- afjk-20251008.xsd (EX-101.SCH) — 4KB
- afjk-20251008_def.xml (EX-101.DEF) — 27KB
- afjk-20251008_lab.xml (EX-101.LAB) — 37KB
- afjk-20251008_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 8, 2025 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer and Director (Principal Executive Officer)